Zhongming Zhao Selected Research

Zhongming Zhao Research Topics

Disease

103	Neoplasms (Cancer) 10/2022 - 06/2010
18	Schizophrenia (Dementia Praecox) 01/2021 - 12/2009
15	Carcinogenesis 06/2021 - 01/2011
11	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2012
7	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2011
5	Mental Disorders (Mental Disorder) 01/2022 - 01/2011
5	COVID-19 11/2021 - 01/2020
5	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2011
5	Alcoholism (Alcohol Abuse) 01/2018 - 01/2009
5	Melanoma (Melanoma, Malignant) 09/2015 - 09/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 03/2012
3	Fibrosis (Cirrhosis) 01/2022 - 08/2011
3	Infections 01/2022 - 01/2021
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 12/2013
3	Hypoxia (Hypoxemia) 01/2021 - 12/2016
3	Heart Failure 01/2020 - 01/2013
3	Tobacco Use Disorder (Nicotine Dependence) 01/2020 - 10/2016
3	Adenocarcinoma 12/2018 - 01/2013
3	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2009
3	Neurocognitive Disorders (Clerambault Syndrome) 06/2017 - 04/2016
2	Carcinoma (Carcinomatosis) 06/2022 - 10/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 01/2020
2	Glioma (Gliomas) 01/2022 - 09/2020
2	Amelogenesis Imperfecta 01/2022 - 02/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2020
2	Obesity 01/2022 - 12/2017
2	Multiple Sclerosis 11/2021 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2013
2	Seminoma 01/2021 - 01/2020
2	Lung Injury 01/2021 - 01/2020
2	Cleft Palate (Palate, Cleft) 01/2020 - 01/2018
2	Weight Gain 01/2018 - 10/2014
2	Thyroid Neoplasms (Thyroid Cancer) 01/2018 - 11/2010
2	Body Weight (Weight, Body) 12/2017 - 01/2012
2	Drug-Related Side Effects and Adverse Reactions 01/2014 - 06/2012
2	Inflammation (Inflammations) 01/2012 - 09/2010
1	Hypersensitivity (Allergy) 10/2022
1	Hypertrophy 01/2022
1	Herpes Simplex 01/2022
1	Insulin Resistance 01/2022
1	Fatty Liver 01/2022

Drug/Important Bio-Agent (IBA)

37	Pharmaceutical PreparationsIBA 01/2022 - 11/2010
31	MicroRNAs (MicroRNA)IBA 05/2022 - 02/2010
31	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
24	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2012
18	Biological ProductsIBA 01/2022 - 05/2010
15	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2010
13	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2009
13	Messenger RNA (mRNA)IBA 01/2020 - 11/2010
10	Phosphotransferases (Kinase)IBA 01/2021 - 11/2010
7	Long Noncoding RNAIBA 09/2020 - 01/2015
6	Tyrosine Kinase InhibitorsIBA 01/2018 - 09/2013
4	LigandsIBA 01/2022 - 09/2015
4	ProteomeIBA 01/2022 - 12/2016
4	Drug CombinationsIBA 11/2021 - 01/2017
4	Antipsychotic Agents (Antipsychotics)IBA 10/2014 - 01/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 03/2012
3	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2010
3	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2009
3	NucleotidesIBA 01/2016 - 01/2013
2	Insulin (Novolin)FDA Link 01/2022 - 03/2012
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2018
2	CateninsIBA 01/2022 - 01/2011
2	Circular RNAIBA 06/2021 - 10/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 11/2020
2	Estrogen ReceptorsIBA 01/2021 - 12/2016
2	SmokeIBA 01/2020 - 10/2016
2	Cocaine (Cocaine HCl)IBA 01/2020 - 01/2018
2	IntegrinsIBA 02/2019 - 01/2017
2	CarcinogensIBA 01/2018 - 12/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 02/2015
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 06/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2016 - 09/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 01/2011
2	Metformin (Glucophage)FDA LinkGeneric 02/2016 - 06/2015
2	Oncogene Proteins (Oncogene Protein)IBA 02/2016 - 05/2015
2	Gefitinib (Iressa)FDA Link 01/2016 - 02/2015
2	P-2 (P 2)IBA 11/2015 - 05/2015
2	Mitogen-Activated Protein KinasesIBA 09/2015 - 02/2015
2	CytokinesIBA 07/2015 - 01/2013
2	ChromatinIBA 05/2015 - 11/2010
2	AfatinibIBA 02/2015 - 05/2014
2	Carrier Proteins (Binding Protein)IBA 07/2014 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 08/2011
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2013 - 09/2010
2	Genetic Markers (Genetic Marker)IBA 07/2012 - 01/2011
2	Ethanol (Ethyl Alcohol)IBA 01/2012 - 01/2009
1	Histamine Antagonists (Antihistamines)IBA 10/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2022
1	Histamine Receptors (Histamine Receptor)IBA 10/2022

Therapy/Procedure

29	Therapeutics 01/2022 - 09/2012
5	Immunotherapy 10/2022 - 01/2021
3	Oncolytic Virotherapy 06/2022 - 01/2021
3	Highly Active Antiretroviral Therapy (HAART) 06/2017 - 01/2014
2	Aftercare (After-Treatment) 01/2022 - 03/2012
2	Drug Therapy (Chemotherapy) 12/2020 - 09/2020
2	Precision Medicine 01/2018 - 01/2014